Medicus Pharma Financials
| MDCX Stock | USD 3.50 0.39 12.54% |
EPS Estimate Current Year (1.80) | EPS Estimate Current Quarter (0.31) |
Medicus | Select Account or Indicator |
Please note, the imprecision that can be found in Medicus Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medicus Pharma Ltd. Check Medicus Pharma's Beneish M Score to see the likelihood of Medicus Pharma's management manipulating its earnings.
Medicus Pharma Stock Summary
Medicus Pharma competes with Western Midstream, Enlight Renewable, Lend Lease, Atmos Energy, and Broadstone Net. Medicus Pharma is traded as part of a regulated electronic trading service offered by the NASD. Medicus Pharma is required by the National Association of Securities Dealers to file current financial statements with the SEC or a bankinginsurance regulator. The quote is listed on Over-The-Counter Bulletin Board , and the company does not need to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges.Specialization | Healthcare, Biotechnology |
| Instrument | USA OTC BB Equity View All |
| Exchange | OTCBB Exchange |
| CUSIP | 58471K202 |
| Sector | Other |
| Industry | Other |
| Benchmark | Dow Jones Industrial |
| Currency | USD - US Dollar |
Medicus Pharma Key Financial Ratios
| Net Income | (6.78 M) | ||||
| Total Asset | 1.89 M | ||||
| Retained Earnings | (19.18 M) |
Medicus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medicus Pharma's current stock value. Our valuation model uses many indicators to compare Medicus Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medicus Pharma competition to find correlations between indicators driving Medicus Pharma's intrinsic value. More Info.Medicus Pharma Ltd is rated top company in current valuation category among its peers. It also is considered to be number one stock in price to earning category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medicus Pharma's earnings, one of the primary drivers of an investment's value.Medicus Pharma Systematic Risk
Medicus Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medicus Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Medicus Pharma correlated with the market. If Beta is less than 0 Medicus Pharma generally moves in the opposite direction as compared to the market. If Medicus Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medicus Pharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medicus Pharma is generally in the same direction as the market. If Beta > 1 Medicus Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Medicus Pharma is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Medicus has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Medicus Pharma's financials are consistent with your investment objective using the following steps:- Review Medicus Pharma's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Medicus Pharma's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Medicus Pharma's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Medicus Pharma's stock is overvalued or undervalued.
Medicus Pharma Thematic Clasifications
Medicus Pharma Ltd is part of Pharmaceutical Products investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
| Pharmaceutical Products | View |
Medicus Pharma March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Medicus Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medicus Pharma Ltd. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medicus Pharma Ltd based on widely used predictive technical indicators. In general, we focus on analyzing Medicus OTC BB Equity price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medicus Pharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 9.09 | |||
| Information Ratio | 0.0686 | |||
| Maximum Drawdown | 43.16 | |||
| Value At Risk | (11.73) | |||
| Potential Upside | 14.74 |
Additional Tools for Medicus OTC BB Equity Analysis
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.